Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
Antônio Waldo Zuardi(Universidade de Ribeirão Preto), Francisco Silveira Guimarães(Universidade de São Paulo), Fabrício A. Moreira(Universidade Federal de Minas Gerais), Jaime E. C. Hallak(Universidade de Ribeirão Preto), J.A.S. Crippa(Universidade de São Paulo)
Cited by 410
Related Papers
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|Journal of Psychopharmacology|2010|530
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
|Brazilian Journal of Psychiatry|2015|484
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression
|Journal of Clinical Psychopharmacology|2015|465